Prognostic Value of Serial Electrocardiographic Voltage and Repolarization Changes in Essential Hypertension: The HEART Survey Study

American Journal of Hypertension

Volumn 20, Issue 9, 2007, Pages 997-1004

  Verdecchia, Paolo ^a   Reboldi, Gianpaolo ^b   Angeli, Fabio ^a   Avanzini, Fausto ^c   de Simone, Giovanni ^d   Pede, Sergio ^e   Perticone, Francesco ^f   Schillaci, Giuseppe ^b   Vanuzzo, Diego ^g   Maggioni, Aldo P ^h  

^a SANTA MARIA DELLA MISERICORDIA HOSPITAL   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

^c DESIO HOSPITAL   (Italy)

^d UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^e Department of Cardiology   (Italy)

^f UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^g UNIVERSITY HOSPITAL OF UDINE   (Italy)

^h ANMCO RESEARCH CENTER   (Italy)

Author keywords

congestive heart failure; Left ventricular hypertrophy; myocardial infarction; stroke; sudden cardiac death

Indexed keywords

ARTICLE; CARDIOVASCULAR RISK; ELECTRIC POTENTIAL; ELECTROCARDIOGRAM; ELECTROCARDIOGRAPHY MONITORING; FOLLOW UP; HEALTH SURVEY; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REPOLARIZATION; ST SEGMENT;

ELECTROCARDIOGRAPHY; FEMALE; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 34548175634     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjhyper.2007.04.003     Document Type: Article

References (30)

1. Levy D., Garrison R.J., Savage D.D., Kannel W.B., and Castelli W.P. Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 322 (1990) 1561-1566
2. Koren M.J., Devereux R.B., Casale P.N., Savage D.D., and Laragh J.H. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 114 (1991) 345-352
3. Levy D., Salomon M., D'Agostino R.B., Belanger A.J., and Kannel W.B. Prognostic implications of baseline electrocardiographic features and their serial changes in subjects with left ventricular hypertrophy. Circulation 90 (1994) 1786-1793
4. Mathew J., Sleight P., Lonn E., Johnstone D., Pogue J., Yi Q., Bosch J., Sussex B., Probstfield J., Yusuf S., and Heart Outcomes Prevention Evaluation (HOPE) Investigators. Reduction of cardiovascular risk by regression of electrocardiographic markers of left ventricular hypertrophy by the angiotensin-converting enzyme inhibitor ramipril. Circulation 104 (2001) 1615-1621
5. Fagard R.H., Staessen J.A., Thijs L., Celis H., Birkenhager W.H., Bulpitt C.J., de Leeuw P.W., Leonetti G., Sarti C., Tuomilehto J., Webster J., Yodfat Y., and Systolic Hypertension in Europe (Syst-Eur) Trial Investigators. Prognostic significance of electrocardiographic voltages and their serial changes in elderly with systolic hypertension. Hypertension 44 (2004) 459-464
6. Okin P.M., Devereux R.B., Jern S., Kjeldsen S.E., Julius S., Nieminen M.S., Snapinn S., Harris K.E., Aurup P., Edelman J.M., Wedel H., Lindholm L.H., Dahlöf B., and LIFE Study Investigators. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive treatment and the prediction of major cardiovascular events. JAMA 292 (2004) 2343-2349
7. Verdecchia P., Angeli F., Borgioni C., Gattobigio R., de Simone G., Devereux R.B., and Porcellati C. Changes in cardiovascular risk by reduction of left ventricular mass in hypertension: a meta-analysis. Am J Hypertens 16 (2003) 895-899
8. Devereux R.B., Casale P.N., Eisenberg R.R., Miller D.H., and Kligfield P. Electrocardiographic detection of left ventricular hypertrophy using echocardiographic determination of left ventricular mass as the reference standard. Comparison of standard criteria, computer diagnosis and physician interpretation. J Am Coll Cardiol 3 (1984) 82-87
9. Levy D., Labib S.B., Anderson K.M., Christiansen J.C., Kannel W.B., and Castelli W.P. Determinants of sensitivity and specificity of electrocardiographic criteria for left ventricular hypertrophy. Circulation 81 (1990) 815-820
10. Romhilt D.W., and Estes E.H. A point-score system for the ECG diagnosis of left ventricular hypertrophy. Am Heart J 75 (1968) 752-759
11. Casale P.N., Devereux R.B., Kligfield P., Eisenberg R.R., Miller D.H., Chaudhary B.S., and Phillips M.C. Electrocardiographic detection of left ventricular hypertrophy: development and prospective validation of improved criteria. J Am Coll Cardiol 6 (1985) 572-580
12. Schillaci G., Verdecchia P., Borgioni C., Ciucci A., Guerrieri M., Zampi I., Battistelli M., Bartoccini C., and Porcellati C. Improved electrocardiographic diagnosis of left ventricular hypertrophy. Am J Cardiol 74 (1994) 714-719
13. Verdecchia P., Schillaci G., Borgioni C., Ciucci A., Gattobigio R., Zampi I., and Porcellati C. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension. J Am Coll Cardiol 31 (1998) 383-390
14. Schillaci G., Pirro M., Pasqualini L., Vaudo G., Ronti T., Gemelli F., Marchesi S., Reboldi G., Porcellati C., and Mannarino E. Prognostic significance of isolated, non-specific left ventricular repolarization abnormalities in hypertension. J Hypertens 22 (2004) 407-414
15. Fagard R., and Syst-Eur Investigators. Response: prognostic significance of serial electrocardiographic repolarization changes. Hypertension 45 (2005) e6
16. Verdecchia P., Sleight P., Avanzini F., de Simone G., Pede S., Perticone F., Schillaci G., Vanuzzo D., Angeli F., Reboldi G.P., and Maggioni A.P. Hypertrophy at ECG and its regression during treatment survey (HEART Survey). Rationale, design and baseline characteristics of patients. Ital Heart J 4 (2003) 479-483
17. Snapinn S.M., Jiang Q., and Iglewicz B. Illustrating the impact of a time-varying covariate with an extended Kaplan-Meier estimate. Am Stat 59 (2005) 301-307
18. Prineas R.J., Rautaharju P.M., Grandits G., Crow R., and MRFIT Research Group. Independent risk for cardiovascular disease predicted by modified continuous score electrocardiographic criteria for 6-year incidence and regression of left ventricular hypertrophy among clinically disease free men: 16-year follow-up for the Multiple Risk Factor Intervention Trial. J Electrocardiol 34 (2001) 91-101
19. Okin P.M., Devereux R.B., Nieminen M.S., Jern S., Oikarinen L., Viitasalo M., Toivonen L., Kjeldsen S.E., Julius S., Snapinn S., Dahlöf B., and LIFE Study Investigators. Electrocardiographic strain pattern and prediction of cardiovascular morbidity and mortality in hypertensive patients. Hypertension 44 (2004) 48-54
20. Kannel W.B., Gordon T., and Offutt D. Left ventricular hypertrophy by electrocardiogram: prevalence, incidence, and mortality in the Framingham Study. Ann Intern Med 71 (1969) 89-105
21. Okin P.M., Devereux R.B., Nieminen M.S., Jern S., Oikarinen L., Viitasalo M., Toivonen L., Kjeldsen S.E., Julius S., and Dahlöf B. Relationship of the electrocardiographic strain pattern to left ventricular structure and function in hypertensive patients: the LIFE Study. J Am Coll Cardiol 38 (2001) 514-520
22. Okin P.M., Devereux R.B., Fabsitz R.R., Lee E.T., Galloway J.M., Howard B.V., and Strong Heart Study. Quantitative assessment of electrocardiographic strain predicts increased left ventricular mass: the Strong Heart Study. J Am Coll Cardiol 40 (2002) 1395-1400
23. Thiry P.S., Rosenberg R.M., and Abbott J.A. A mechanism for the electrocardiogram in response to left ventricular hypertrophy and acute ischemia. Circ Res 36 (1975) 92-104
24. Rembert J.C., Kleinman L.H., Fedor J.M., Wechsler A.S., and Greenfield Jr. J.C. Myocardial blood flow distribution in concentric left ventricular hypertrophy. J Clin Invest 62 (1978) 379-386
25. Galderisi M., de Simone G., Cicala S., De Simone L., D'Errico A., Caso P., and de Divitiis O. Coronary flow reserve in hypertensive patients with appropriate or inappropriate left ventricular mass. J Hypertens 21 (2003) 2183-2188
26. Kozakova M., de Simone G., Morizzo C., and Palombo C. Coronary vasodilator capacity and hypertension-induced increase in left ventricular mass. Hypertension 41 (2003) 224-229
27. Salles G., Cardoso C., Nogueira A.R., Bloch K., and Muxfeldt E. Importance of the electrocardiographic strain pattern in patients with resistant hypertension. Hypertension 48 (2006) 1-6
28. Okin P.M., Jern S., Devereux R.B., Kjeldsen S.E., Dahlöf B., and LIFE Study Group. Effect of obesity on electrocardiographic left ventricular hypertrophy in hypertensive patients. The Losartan Intervention for Endpoint (LIFE) Reduction in Hypertension Study. Hypertension 35 (2000) 13-18
29. Hypertension Detection and Follow-Up Program Cooperative Group. Five-year findings of the Hypertension Detection and Follow-Up Program: prevention and reversal of left ventricular hypertrophy with antihypertensive drug therapy. Hypertension 7 (1985) 105-112
30. Okin P.M., Devereux R.B., Jern S., Kjeldsen S.E., Julius S., Nieminen M.S., Snapinn S., Harris K.E., Aurup P., Edelman J.M., Dahlöf B., and Losartan Intervention for Endpoint Reduction in Hypertension Study Investigations. Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: the Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study. Circulation 108 (2003) 684-690